Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ODYY | Stock Option (Right to Buy) | Award | $318K | +1M | +90.91% | $0.32 | 2.1M | Oct 14, 2022 | Common Stock | 1M | $0.32 | Direct | F1 |
Id | Content |
---|---|
F1 | Vesting Schedule 250,000 upon signing; 250,000 upon an IND being approved by the FDA for Phase 2; 250,000 upon a listing on a national exchange (Nasdaq, NYSE); and 250,000 one year from Effective Date. |